 Esperion Therapeutics Inc NASDAQ: ESPR priced its previously announced underwritten public offering of 32.14 million shares and short-term warrants to purchase up to 32.14 million shares at 7share and accompanying warrant. The short-term warrants have an exercise price of 9.00 per share, are exercisable immediately, and will expire two years following the date of issuance. 